MARKET

ACHV

ACHV

Achieve Life Sciences Inc
NASDAQ
3.090
+0.020
+0.65%
After Hours: 3.230 +0.14 +4.53% 17:39 01/17 EST
OPEN
3.090
PREV CLOSE
3.070
HIGH
3.140
LOW
3.020
VOLUME
379.92K
TURNOVER
--
52 WEEK HIGH
5.59
52 WEEK LOW
3.020
MARKET CAP
106.26M
P/E (TTM)
-2.7381
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACHV last week (0106-0110)?
Weekly Report · 6d ago
Achieve Life Sciences Announces Board of Directors Changes
TipRanks · 01/10 14:49
ACHIEVE LIFE SCIENCES APPOINTS DR. KRISTEN SLAOUI AND NANCY PHELAN TO ITS BOARD OF DIRECTORS
Reuters · 01/10 13:30
Press Release: Achieve Life Sciences Appoints Dr. -2-
Dow Jones · 01/10 13:30
Press Release: Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors
Dow Jones · 01/10 13:30
Oppenheimer Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)
TipRanks · 01/08 12:36
Achieve Life Sciences (ACHV) Gets a Buy from JonesTrading
TipRanks · 01/07 15:15
Achieve Life Sciences reaches milestone for ORCA-OL cytisinicline trial
TipRanks · 01/07 13:42
More
About ACHV
Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of action that is both agonistic and antagonistic. Cytisinicline is a partial agonist that binds with high affinity to the alpha-4 beta-2, nicotinic acetylcholine receptors in the brain. Through its dual-acting partial agonist/partial antagonist activity, cytisinicline helps reduce nicotine cravings, withdrawal symptoms and reward and satisfaction associated with smoking. It is developing cytisinicline as an aid to smoking cessation and treatment for nicotine addiction to address the limitations of both prescription drugs and of over the counter (OTC) products.

Webull offers Achieve Life Sciences Inc stock information, including NASDAQ: ACHV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACHV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACHV stock methods without spending real money on the virtual paper trading platform.